Clinical Trial Initiative
Arkansas
Accelerator
Statewide
SymBiosis and HealthTech Arkansas have partnered to create an accelerator program for biotherapeutics companies aiming to start a clinical trial within 12 months.
Key Information
- This program focuses on advanced and emerging therapeutic modalities applied to serious and lifethreatening diseases, including precision medicines, biologics, cell therapies, and genetic medicines, in areas such as oncology, immunology, and cardiometabolic diseases.
Additional Resources
Contact Information
Share This Program